The store will not work correctly when cookies are disabled.
5-(6-hydroxybenzofuran-2-yl)-2-(3-methylbut-1-enyl)benzene-1,3-diol
ID: ALA4281040
Cas Number: 936006-11-0
PubChem CID: 71307312
Max Phase: Preclinical
Molecular Formula: C19H18O4
Molecular Weight: 310.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)/C=C/c1c(O)cc(-c2cc3ccc(O)cc3o2)cc1O
Standard InChI: InChI=1S/C19H18O4/c1-11(2)3-6-15-16(21)7-13(8-17(15)22)18-9-12-4-5-14(20)10-19(12)23-18/h3-11,20-22H,1-2H3/b6-3+
Standard InChI Key: YVWWLJFWZOKLLA-ZZXKWVIFSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
15.3354 -24.3217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3342 -25.1413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0423 -25.5502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0405 -23.9129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7491 -24.3181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7539 -25.1367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5339 -25.3852 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.0113 -24.7201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5262 -24.0607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6262 -25.5493 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.8285 -24.7152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2386 -25.4217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0551 -25.4172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4603 -24.7066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0431 -23.9989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2281 -24.0069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4675 -26.1227 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.4450 -23.2874 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.2775 -24.7007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6912 -25.4054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5083 -25.3995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9220 -26.1042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9118 -24.6888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
2 10 1 0
8 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
13 17 1 0
15 18 1 0
14 19 1 0
19 20 2 0
20 21 1 0
21 22 1 0
21 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 310.35 | Molecular Weight (Monoisotopic): 310.1205 | AlogP: 4.89 | #Rotatable Bonds: 3 |
Polar Surface Area: 73.83 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.63 | CX Basic pKa: ┄ | CX LogP: 4.64 | CX LogD: 4.62 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.64 | Np Likeness Score: 1.34 |
References
1. Hu C, Ma S.. (2018) Recent development of lipoxygenase inhibitors as anti-inflammatory agents., 9 (2): [PMID:30108915] [10.1039/C7MD00390K] |